Monday, December 3, 2018

Alembic Pharma#39;s subsidiary gets USFDA nod peptic ulcer drug

Alembic Pharma#39;s subsidiary gets USFDA nod peptic ulcer drug The company#39;s wholly owned subsidiary Orit Laboratories LLC has received approval from the US Food Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Glycopyrrolate tablets USP in the strengths of 1 mg and 2mg, Alembic Pharmaceuticals said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2Qgj9ks
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...